Contribute Information
Can you contribute information about this project?
Contact the EWS Team
According to the Bank’s website, IFC is considering an equity investment of up to US$10 million in Alkemi Venture Fund II – Scheme I (“Alkemi II” or the “Fund”), an India domiciled, early-stage venture capital fund exclusively focused on healthcare.
The Fund will invest in pre-Series A, and Series A stage companies in the healthtech and wellness sector (healthcare delivery, diagnostics, med-tech, insure-tech, healthcare SaaS, pharma supply chain etc.). The Fund will not invest in any coal-related activities or higher risk business activities that may include a) involuntary resettlement, b) risk of adverse impacts on indigenous peoples, c) significant risks to or impacts on the environment, community health and safety, biodiversity, cultural heritage, d) risk of significant retrenchment or e) significant occupational health and safety risks. The main E&S risks and impacts of this Project derive from activities of Fund’s investee companies and their E&S capacity and systems in place to manage these risks as well as the fund manager’s capacity to adequately assess E&S risks, require corrective actions where needed, and monitor their implementation. Overall, E&S risks of the proposed project are medium-low, and the project has been classified as a Category FI-2 project according to IFC Sustainability Policy.
The Fund is targeting to raise US$75 million and has reached a first-close of US$49.7 million.
IFC has proposed an equity investment of up to US$10 million (not to exceed 20% of total fund size) and a co-investment envelope of US$5 million.
IFC's Investment as Approved by the Board: Equity 15.0 million (USD)
The Fund will be managed by Alkemi Growth Capital LLP (“Alkemi” or “Fund Manager”), a female-led second time fund manager. Alkemi is led by Alka Goel (Founder and Managing Partner) and Dr. Mansi Aggarwal (Partner).
Alkemi Growth Capital LLP
Alka Goel
Managing Partner
+91 11 2614 3600
sayhello@alkemivp.com
90/12, Malviya Nagar, New Delhi 110017, India
https://www.alkemivp.com/
ACCESS TO INFORMATION
You can submit a request for information disclosure at: https://disclosures.ifc.org/#/inquiries
If you believe that your request for information from IFC has been unreasonably denied, or that this Policy has been interpreted incorrectly, you can submit a complaint at the link above to IFC's Access to Information Policy Advisor, who reports directly to IFC's Executive Vice President.
ACCOUNTABILITY MECHANISM OF IFC/MIGA
The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at CAO@worldbankgroup.org You can learn more about the CAO and how to file a complaint at http://www.cao-ombudsman.org